Related Experiment Videos
Reserpine induced intraneuronal dopamine oxidation: reversal by MPP+ action
1Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York 10962.
Life Sciences
|January 1, 1991
Summary
1-methyl-4-phenylpyridinium ion (MPP+) significantly increases dopamine levels in reserpine-treated synaptosomes, suggesting intraneuronal dopamine release. This MPP+ action appears independent of uptake and may involve MAO inhibition.
Area of Science:
- Neuroscience
- Neurochemistry
- Pharmacology
Background:
- Dopamine is a crucial neurotransmitter implicated in various neurological functions.
- 1-methyl-4-phenylpyridinium ion (MPP+) is a neurotoxin linked to dopaminergic neuron degeneration.
- Reserpine depletes monoamines, including dopamine, by inhibiting vesicular storage.
Purpose of the Study:
- To investigate the effects of MPP+ on dopamine levels in striatal synaptosomes.
- To elucidate the role of reserpine in modulating MPP+'s impact on dopamine.
- To explore the mechanism underlying MPP+-induced dopamine changes.
Main Methods:
- Incubation of striatal synaptosomes with MPP+ and/or reserpine.
- Measurement of dopamine levels in the incubation medium.
- Determination of MPP+ uptake and corresponding dopamine increase.
Main Results:
- MPP+ enhanced dopamine levels in the presence of tyrosine, but less so with alpha-methyl-p-tyrosine.
- Reserpine drastically reduced basal dopamine levels but potentiated MPP+'s dopamine-elevating effect.
- MPP+ uptake was lower than the resultant dopamine increase, suggesting a non-transport-dependent mechanism.
Conclusions:
- Reserpine treatment potentiates MPP+'s ability to increase extracellular dopamine, likely via intraneuronal release.
- MPP+'s action appears independent of countertransport mechanisms.
- MPP+ may act as a potent inhibitor of intraneuronal monoamine oxidase (MAO).